Literature DB >> 17542995

API2-MALT1 chimeric transcript-positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years.

T Isaka, T Nakamura, M Tajika, H Kawai, H Imaoka, Y Okamoto, M Aoki, H Inoue, K Takahashi, N Mizuno, A Sawaki, K Yamao, M Seto, T Yokoi, Y Yatabe, S Nakamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17542995     DOI： 10.1111/j.1365-2559.2007.02718.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  5 in total

1.  Collision tumor of carcinoma and lymphoma in the cecum: case report and review of literature.

Authors:  Lei Bao; Xiaoli Feng; Ting Wang; Fengjuan Xing
Journal:  Int J Clin Exp Pathol       Date:  2020-11-01

Review 2.  Helicobacter and gastric malignancies.

Authors:  António Carlos Ferreira; Hajime Isomoto; Masatsugu Moriyama; Toshio Fujioka; José Carlos Machado; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2008-10       Impact factor: 5.753

3.  Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.

Authors:  J Lehmann-Che; F Amira-Bouhidel; E Turpin; M Antoine; H Soliman; L Legres; C Bocquet; R Bernoud; E Flandre; M Varna; A de Roquancourt; L-F Plassa; S Giacchetti; M Espié; C de Bazelaire; L Cahen-Doidy; E Bourstyn; A Janin; H de Thé; P Bertheau
Journal:  Br J Cancer       Date:  2011-05-03       Impact factor: 7.640

Review 4.  Gastric collision tumors: an insight into their origin and clinical significance.

Authors:  Adamantios Michalinos; Anastasia Constantinidou; Michael Kontos
Journal:  Gastroenterol Res Pract       Date:  2015-02-12       Impact factor: 2.260

Review 5.  Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma in the Gastrointestinal Tract in the Modern Era.

Authors:  Eri Ishikawa; Masanao Nakamura; Akira Satou; Kazuyuki Shimada; Shotaro Nakamura
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.